From drug evaluation to that of a path: the challenges for regulatory authorities.
Recenti progressi in medicina, 2021-02, Vol.112 (2), p.146
[Peer Reviewed Journal]
EISSN: 2038-1840 ;DOI: 10.1701/3559.35377 ;PMID: 33624629
Digital Resources/Online E-Resources